Breast cancer heterogeneity and its implication in personalized precision therapy

L Guo, D Kong, J Liu, L Zhan, L Luo, W Zheng… - … hematology & oncology, 2023 - Springer
Breast cancer heterogeneity determines cancer progression, treatment effects, and
prognosis. However, the precise mechanism for this heterogeneity remains unknown owing …

The role of p53 in anti-tumor immunity and response to immunotherapy

L Carlsen, S Zhang, X Tian, A De La Cruz… - Frontiers in Molecular …, 2023 - frontiersin.org
p53 is a transcription factor that regulates the expression of genes involved in tumor
suppression. p53 mutations mediate tumorigenesis and occur in approximately 50% of …

p53 at the crossroads of tumor immunity

G Efe, AK Rustgi, C Prives - Nature Cancer, 2024 - nature.com
The p53 tumor suppressor protein has a plethora of cell-intrinsic functions and
consequences that impact diverse cell types and tissues. Recent studies are beginning to …

Master regulator: p53's pivotal role in steering NK-cell tumor patrol

H Wang, Q Chen, Q Liu, C Luo - Frontiers in Immunology, 2024 - frontiersin.org
The p53 protein, encoded by TP53, is a tumor suppressor that plays a critical role in
regulating apoptosis, cell cycle regulation, and angiogenesis in tumor cells via controlling …

Emerging Role of the p53 Pathway in Modulating Natural Killer Cell Mediated Immunity

YC Chen, CG Bazewicz, SS Dinavahi… - Molecular Cancer …, 2024 - aacrjournals.org
The p53 pathway plays an important role in role in cancer immunity. Mutation or
downregulation of the proteins in the p53 pathway are prevalent in many cancers …

In-depth analysis of the interplay between oncogenic mutations and NK cell-mediated cancer surveillance in solid tumors

C Pesini, L Artal, J Paúl Bernal… - …, 2024 - Taylor & Francis
Natural killer (NK) cells play a crucial role in antitumoral and antiviral responses. Yet, cancer
cells can alter themselves or the microenvironment through the secretion of cytokines or …

TP53 to mediate immune escape in tumor microenvironment: an overview of the research progress

K Zhu, F Su, J Yang, R Xiao, R Wu, M Cao… - Molecular Biology …, 2024 - Springer
Increasing evidence suggests that key cancer-causing driver genes continue to exert a
sustained influence on the tumor microenvironment (TME), highlighting the importance of …

Glucocorticoids in Lung Cancer: Navigating the Balance Between Immunosuppression and Therapeutic Efficacy

W Xu, J Ye, Z Cao, Y Zhao, Y Zhu, L Li - Heliyon, 2024 - cell.com
Glucocorticoids (GCs), a class of hormones secreted by the adrenal glands, are released
into the bloodstream to maintain homeostasis and modulate responses to various stressors …

Mtp53 对肿瘤免疫的调控及其在免疫治疗中的应用.

曹其右, 狄翠霞, 王俊玲 - Chinese Journal of Biochemistry & …, 2024 - search.ebscohost.com
Mtp53 对肿瘤免疫的调控及其在免疫治疗中的应用 Page 1 ISSN 1007⁃7626 CN 11⁃3870/Q 中国
生物化学与分子生物学报http:/ / cjbmb. bjmu. edu. cn Chinese Journal of Biochemistry and …

[HTML][HTML] Restoration of Tumor Suppression to Cancer Carrying p53 Mutations

MN Amin, YY Liu - 2023 - intechopen.com
Missense mutations of tumor suppressor genes enable cancerous cells generating variable
mutant proteins and promote malignant development. These mutant proteins lose the …